Replimune Group, Inc. (REPL) Income Tax Expense (Benefit) USD 2022 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Replimune Group, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2022 to 2024.
  • Replimune Group, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$65 K, a 123% decline year-over-year.
  • Replimune Group, Inc. Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was $408 K, a 41.7% increase year-over-year.
  • Replimune Group, Inc. annual Income Tax Expense (Benefit) for 2023 was $408 K, a 41.7% increase from 2022.
  • Replimune Group, Inc. annual Income Tax Expense (Benefit) for 2022 was $288 K.
  • Replimune Group, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $408 K -$65 K -$353 K -123% Jan 1, 2024 Mar 31, 2024 10-K 2024-05-16
Q4 2023 $761 K $473 K +$473 K Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-08
Q3 2023 $288 K -$201 K -$201 K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $489 K $201 K +$201 K Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $288 K $288 K Jan 1, 2023 Mar 31, 2023 10-K 2024-05-16
Q4 2022 $0 Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-08
Q3 2022 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.